Additionally, hydrogel systems, such as those incorporating paclitaxel and mifepristone, or combining chemoimmunotherapy agents like pembrolizumab and IFN-γ, demonstrated potential in reducing tumor metastasis and enhancing immune responses [121,133]. This evidence concerns the gene IFNG and neoplasm.